[1]
Yahcoob, N. et al. 2017. In-silico screening of 2,3-diphenylquinozaline derivatives as C-met kinase inhibitors. Journal of Pharmaceutical Chemistry. 4, 3 (Aug. 2017), 41–45. DOI:https://doi.org/10.14805/jphchem.2017.art84.